z-logo
Premium
Relapse of neuromyelitis optica with occipital neuralgia and elevated CSF neopterin
Author(s) -
Miyaue Noriyuki,
Yabe Hayato,
Yamanishi Yuki,
Tada Satoshi,
Ando Rina,
Nagai Masahiro
Publication year - 2020
Publication title -
neurology and clinical neuroscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
0
ISSN - 2049-4173
DOI - 10.1111/ncn3.12393
Subject(s) - medicine , neuromyelitis optica , cerebrospinal fluid , pleocytosis , neopterin , myelopathy , lymphocytic pleocytosis , magnetic resonance imaging , occipital neuralgia , pathology , dysesthesia , spinal cord , gastroenterology , radiology , anesthesia , neuralgia , multiple sclerosis , immunology , encephalitis , neuropathic pain , virus , psychiatry
A 64‐year‐old woman with anti‐aquaporin‐4 antibody‐positive neuromyelitis optica presented with pain and dysesthesia in the left occipital region. Cervical magnetic resonance imaging showed a new high‐intensity area on the left side of the spine (C1‐C2 level), close to a pre‐existing lesion. Cerebrospinal fluid analysis revealed elevated neopterin (53.1 nmol/L) without pleocytosis. The neopterin level normalized 2 weeks (22.0 nmol/L) and 2 months (18.9 nmol/L) after intensified steroid therapy. Occipital neuralgia should be considered a common clinical feature of neuromyelitis optica, and cerebrospinal fluid neopterin may be a useful, sensitive biomarker for central nervous system inflammation in these patients.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom